In third part of his Pharma Commerce video interview, Faisal Khan, a GRC solutions expert with Vanta, emphasizes the need for ...
WeightWatchers intends to offer Novo Nordisk’s pill version of Wegovy if it makes its US debut next year following potential ...
This episode of Pharma Pulse discusses how the FDA’s new plausible mechanism pathway, WeightWatchers’ plans to offer oral Wegovy, and emerging evidence on berberine are shaping the future of obesity ...
Following LogiPharma USA 2025, the editors of Pharmaceutical Commerce explore the latest trends and key takeaways from the event, with a focus on the cold chain solutions sector.
This episode of Pharma Pulse explores how regulators modernize safety information for hormone therapy, new data that ...
Novartis has unveiled a 10,000-square-foot radioligand therapy (RLT) production plant in Carlsbad, CA, representing a move ...
Pharma Pulse: FDA Appoints Richard Pazdur as CDER Director Amid 340B Tensions and Novartis Expansion
This episode of Pharma Pulse discusses how Dr. Richard Pazdur’s appointment signals a new era for FDA drug evaluation, why hospitals are opposing the government’s 340B pilot program, and how Novartis ...
This episode of Pharma Pulse explores a major review finding no link between maternal acetaminophen use and autism or ADHD, ...
DSCSA compliance is only the beginning. Is your warehouse ready for the challenges it brings? Without the right strategies in place, compliance can create bottlenecks, delay shipments, and lead to ...
This episode of Pharma Pulse discusses FDA’s growing National Priority Voucher initiative, fresh data on oral semaglutide’s ...
Arsenal Capital Partners acquired ThermoSafe for up to $725 million, strengthening its cold chain packaging capabilities.
Launching next year, the new CMS Innovation Center initiative—known as the GENEROUS Model—aims to align Medicaid drug prices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback